Featured

Trump Launches TrumpRx to Lower Drug Costs

The Trump administration unveiled TrumpRx.gov on Feb.5, a direct-to-consumer website it says will help patients buy prescription drugs at a discounted rate if they pay cash rather than through their health insurance.

“You’re going to save a fortune,” President Donald Trump said during the launch event. “And this is also so good for overall health care.”

The website launched with 43 drugs from five companies that reached agreements with the Trump administration, including AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer. According to the White House, discounts from an additional 11 companies that have reached deals with the administration will be available over the coming months.

"It's the biggest thing to happen in health care, I think, in many, many decades," President Trump added.

The government-operated platform is set up as a central hub, guiding patients to drugmakers’ direct-to-consumer sites where discounts are offered on certain products, or providing Americans with discount coupons to use at pharmacies.

In recent months, Pfizer, Lily, and at least 14 other drugmakers have negotiated deals with the administration to participate on the website and voluntarily provide certain medications at a lower cost to Medicaid patients.

President Trump and his administration announced the TrumpRx concept in the fall of 2025 as part of an agreement with pharmaceutical companies to provide lower prices for American consumers. Drugmakers agreed to lower their rates for Medicaid, administer future new drugs at prices similar to those in other wealthy nations, and offer discounts through the platform, as mentioned previously, in exchange for exemptions from certain tariffs.

“We’re tired of subsidizing the world,” Trump expressed during the event, referring to the prices of medications.

The website is the Trump administration’s latest attempt to tackle U.S prescription drug pricing, which, according to the Rand Corp., a public policy think tank, is on average two to three times higher than in other developed countries and up to 10 times higher than in some others.

Joseph Quesada

Joseph Quesada is an award-winning video editor and Miami-based reporter covering national and international politics. He is a junior Political Science major at Florida International University with a minor in Visual Production. With nearly a decade of experience in digital video production, he enjoys creating video content and weightlifting in his free time.

Recent Posts

Texas Emerges as a Key Hub For Israeli Investment

A new report from 5W Public Relations has highlighted a rapidly growing but seemingly overlooked…

7 hours ago

Ken Paxton Sues Houston 'Birth Tourism' Business

Attorney General Ken Paxton (R-TX) filed a lawsuit Wednesday against a Houston-area business called De'Ai…

7 hours ago

House Passes Long-Delayed Farm Bill in Close 224–200 Vote

The House of Representatives in Washington, D.C., passed the 2026 Farm Bill by a vote…

7 hours ago

James Talarico Leads Both John Cornyn and Ken Paxton in New Poll

A new statewide poll from Texas Public Opinion Research (TPOR) is reshaping early expectations for…

7 hours ago

Ted Cruz Sounds the Alarm on Religious Freedom Violations in Tanzania

U.S. Senator Ted Cruz (R) is calling attention to alleged religious freedom violations in Tanzania,…

9 hours ago

LONESTAR — 4.30.2026 — Major Solar Deal Boosts Texas Energy — Talarico Pledges National Reform on Redistricting — and More...

Graphic Packaging Signs Major Solar Deal for New Texas Energy Project Graphic Packaging Holding Company…

12 hours ago